세계의 도코사헥사엔산(DHA) 영양제 시장 보고서(2025년)
Docosahexaenoic Acid (DHA) Supplements Global Market Report 2025
상품코드 : 1889364
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,718,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,710,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,703,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

도코사헥사엔산(DHA) 영양제 시장의 규모는 최근 급속도로 확대되고 있습니다. 2024년의 19억 2,000만 달러에서 2025년에는 21억 2,000만 달러로, CAGR 10.5%로 성장할 전망입니다. 지난 수년간의 성장은 온라인 및 디지털 유통 채널 확대, 신흥 시장에서 중산층의 소득 증가, 클린 라벨 제품 및 알레르겐 프리 제품에 대한 수요 증가, 고령화 인구 증가, 영양제 제품의 프리미엄화와 관련이 있습니다.

도코사헥사엔산(DHA) 영양제 시장의 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 31억 2,000만 달러에 달하고, CAGR은 10.2%를 나타낼 전망입니다. 예측기간의 성장은 소비자의 건강 의식 증가, 생활습관병 증가에 의한 예방적 이용의 확대, 영유아 및 임산부용 영양부문의 확대, 기능성 강화 식음료의 증가, 비건과 채식의 보급 확대에 의해 견인될 가능성이 있습니다. 예측 기간의 주요 동향은 추출 기술의 진보, 마이크로캡슐화 및 나노 전달 시스템의 진보, 제형 혁신의 진보, 공급 체인 추적성 및 투명성 기술의 진보, 맞춤 영양 및 디지털 건강 플랫폼의 진보가 있습니다.

영양제의 보급 확대는 도코사헥사엔산(DHA) 영양제 시장의 성장을 이끌 것으로 예측됩니다. 비타민, 미네랄, 허브 및 기타 영양소를 포함한 영양제는 영양 상태를 개선하고 종합적인 건강 증진을 위해 설계되었습니다. 건강과 웰빙에 대한 의식이 높아짐에 따라 질병 예방과 균형 잡힌 영양 섭취를 촉진하는 추가 영양소를 요구하는 소비자가 증가하고 있습니다. 특히 DHA 영양제는 영양 부족의 해소, 인지 기능의 발달 지원, 심혈관 건강 증진, 종합적인 건강 상태의 개선에 효과가 있어 인기를 끌고 있습니다. 예를 들어, 2025년 9월에 호주 통계국이 발표한 데이터에 의하면, 2023년에는 2세 이상의 인구의 약 33.6%(약 850만명)가 영양보조식품을 이용하고 있었으며, 이는 2022년 대비 17% 증가를 나타내고 있습니다. 영양보조식품의 이용 확대가 DHA 영양제 시장의 성장을 견인하는 주요 요인이 되고 있습니다.

DHA 영양제 시장의 기업은 조류유 유래의 다가 불포화 지방산(PUFA) 영양제 등 새로운 제품 개발에 주력하고 있습니다. 이러한 제품은 생체이용효율 향상, 지속가능성, 소비자를 위한 건강효과를 제공합니다. 조류유 유래 PUFA 영양제는 조류를 원료로 하는 영양이 풍부한 제품으로, 특히 DHA를 풍부하게 함유한 오메가3 지방산을 공급합니다. 또한 인지 기능, 심혈관 건강 및 전반적인 건강 상태 유지를 지원합니다. 예를 들어 2024년 12월에는 미국에 본사를 둔 영양보조식품기업 네이처스 바운티사가 기존의 어유를 대체하는 채식주의 대체품으로서 식물 유래의 오메가3 영양제를 출시했습니다. 소프트젤 하나로 EPA와 DHA를 포함한 520mg의 오메가3 지방산을 섭취할 수 있어 심장, 관절, 피부의 건강 유지를 지원합니다. 이 식물 유래 제품은 지속 가능한 방법으로 제조되고 무취이므로 순환 기능 에너지 대사 심장혈관 지원 효과를 기대하는 식물 유래 건강 지향 소비자에게 최적입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장의 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

CSM
영문 목차

영문목차

Docosahexaenoic acid (DHA) supplements are specialized dietary products that provide DHA, a vital omega-3 fatty acid crucial for optimal brain, eye, and heart health. These supplements are widely used by people of all ages, including pregnant women, infants, and adults, to support cognitive development, maintain overall wellness, and address dietary deficiencies in omega-3s.

The key types of docosahexaenoic acid (DHA) supplements are fatty acids, phospholipids, seafood fats and oils, and others. Fatty acids are organic compounds that act as the essential building blocks of lipids and provide vital nutrients. Available product forms include capsules, softgels, gummies, powders, and others and are sourced from fish oil, algal oil, krill oil, and others. These are distributed through online stores, supermarkets or hypermarkets, specialty stores, and others and are primarily used in applications including infant formula, dietary supplements, functional food and beverages, pharmaceuticals, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The docosahexaenoic acid (DHA) supplements market research report is one of a series of new reports from The Business Research Company that provides docosahexaenoic acid (DHA) supplements market statistics, including docosahexaenoic acid (DHA) supplements industry global market size, regional shares, competitors with a docosahexaenoic acid (DHA) supplements market share, detailed docosahexaenoic acid (DHA) supplements market segments, market trends and opportunities, and any further data you may need to thrive in the docosahexaenoic acid (DHA) supplements industry. This docosahexaenoic acid (DHA) supplements market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The docosahexaenoic acid (DHA) supplements market size has grown rapidly in recent years. It will grow from $1.92 billion in 2024 to $2.12 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be linked to increasing online and digital distribution channels, growing middle-class incomes in emerging markets, increasing demand for clean-label and allergen-free products, a rising ageing population, and increasing premiumization of supplement products.

The docosahexaenoic acid (DHA) supplements market size is expected to see rapid growth in the next few years. It will grow to $3.12 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be driven by rising health consciousness among consumers, growing lifestyle-related disorders driving preventive use, expansion of the infant and maternal nutrition segment, increasing fortified functional foods and beverages, and rising adoption of vegan or vegetarian diets. Major trends in the forecast period include advancement in extraction technologies, advancement in micro-encapsulation and nano-delivery systems, advancement in formulation innovation, advancement in supply-chain traceability and transparency technologies, and advancement in personalized nutrition and digital health platforms.

The growing adoption of dietary supplements is expected to drive the growth of the docosahexaenoic acid (DHA) supplements market. Dietary supplements, which contain vitamins, minerals, herbs, or other nutrients, are designed to enhance nutrition and support overall well-being. The rising awareness of health and wellness has led more consumers to seek additional nutrients that promote disease prevention and balanced nutrition. DHA supplements, in particular, have gained popularity for their ability to fill nutritional gaps, support cognitive development, enhance cardiovascular health, and improve overall wellness. For instance, in September 2025, the Australian Bureau of Statistics reported that around 33.6% of individuals aged 2 years and older-approximately 8.5 million people-used dietary supplements in 2023, a 17% increase from 2022. This growing adoption of dietary supplements is a key factor driving the expansion of the DHA supplements market.

Companies in the DHA supplements market are innovating with new products, such as algal oil-derived polyunsaturated fatty acid (PUFA) supplements, which offer improved bioavailability, sustainability, and health benefits targeted to consumers. Algal oil-derived PUFA supplements are nutrient-rich products sourced from algae, providing high levels of omega-3 fatty acids, particularly DHA, which support cognitive function, cardiovascular health, and overall well-being. For example, in December 2024, Nature's Bounty, a U.S.-based dietary supplements company, launched a plant-based omega-3 supplement as a vegetarian alternative to traditional fish oil. Just one softgel provides 520 mg of omega-3s, including EPA and DHA, supporting heart, joint, and skin health. This plant-based option is sustainably produced, odorless, and ideal for those seeking plant-based wellness with benefits for circulation, energy metabolism, and cardiovascular support.

In October 2024, KD Pharma Group SA, a Switzerland-based pharmaceutical company, acquired DSM-Firmenich's Marine Lipids business for an undisclosed amount. This acquisition positions KD Pharma as the world's largest omega-3 manufacturer, enabling it to expand its leadership across the entire omega-3 value chain, strengthen global production and distribution capabilities, and diversify its product offerings in the food, dietary supplement, and pharmaceutical sectors. DSM-Firmenich's Marine Lipids business specializes in providing DHA supplements and complements KD Pharma's strategic goals in the omega-3 market.

Major companies operating in the docosahexaenoic acid (dha) supplements market are Archer Daniels Midland Company, BASF SE, Stepan Company, Corbion N.V., Pharmavite LLC, Neptune Wellness Solutions Inc., NOW Foods, Bioplus Life Sciences Private Limited, KD Pharma Group SA, Nordic Naturals Inc., Clover Corporation Limited, Arjuna Natural Extracts Ltd., Aker BioMarine AS, Source Omega LLC, Epax Norway AS, Jiangsu Auqi Marine Biotechnology Co. Ltd., Navchetana Kendra Health Care Private Limited, Novotech Nutraceuticals Inc., AlgalR NutraPharms, Koninklijke DSM N.V., Huve Nutraceuticals Ltd.

North America was the largest region in the docosahexaenoic acid (DHA) supplements market in 2024. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the docosahexaenoic acid (DHA) supplements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The docosahexaenoic acid (DHA) supplements market consists of sales of chewable tablets, nut butters enriched with docosahexaenoic acid, and ready-to-drink nutritional shakes or smoothies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Docosahexaenoic Acid (DHA) Supplements Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on docosahexaenoic acid (dha) supplements market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for docosahexaenoic acid (dha) supplements ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The docosahexaenoic acid (dha) supplements market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Docosahexaenoic Acid (DHA) Supplements Market Characteristics

3. Docosahexaenoic Acid (DHA) Supplements Market Trends And Strategies

4. Docosahexaenoic Acid (DHA) Supplements Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Docosahexaenoic Acid (DHA) Supplements Growth Analysis And Strategic Analysis Framework

6. Docosahexaenoic Acid (DHA) Supplements Market Segmentation

7. Docosahexaenoic Acid (DHA) Supplements Market Regional And Country Analysis

8. Asia-Pacific Docosahexaenoic Acid (DHA) Supplements Market

9. China Docosahexaenoic Acid (DHA) Supplements Market

10. India Docosahexaenoic Acid (DHA) Supplements Market

11. Japan Docosahexaenoic Acid (DHA) Supplements Market

12. Australia Docosahexaenoic Acid (DHA) Supplements Market

13. Indonesia Docosahexaenoic Acid (DHA) Supplements Market

14. South Korea Docosahexaenoic Acid (DHA) Supplements Market

15. Western Europe Docosahexaenoic Acid (DHA) Supplements Market

16. UK Docosahexaenoic Acid (DHA) Supplements Market

17. Germany Docosahexaenoic Acid (DHA) Supplements Market

18. France Docosahexaenoic Acid (DHA) Supplements Market

19. Italy Docosahexaenoic Acid (DHA) Supplements Market

20. Spain Docosahexaenoic Acid (DHA) Supplements Market

21. Eastern Europe Docosahexaenoic Acid (DHA) Supplements Market

22. Russia Docosahexaenoic Acid (DHA) Supplements Market

23. North America Docosahexaenoic Acid (DHA) Supplements Market

24. USA Docosahexaenoic Acid (DHA) Supplements Market

25. Canada Docosahexaenoic Acid (DHA) Supplements Market

26. South America Docosahexaenoic Acid (DHA) Supplements Market

27. Brazil Docosahexaenoic Acid (DHA) Supplements Market

28. Middle East Docosahexaenoic Acid (DHA) Supplements Market

29. Africa Docosahexaenoic Acid (DHA) Supplements Market

30. Docosahexaenoic Acid (DHA) Supplements Market Competitive Landscape And Company Profiles

31. Docosahexaenoic Acid (DHA) Supplements Market Other Major And Innovative Companies

32. Global Docosahexaenoic Acid (DHA) Supplements Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Docosahexaenoic Acid (DHA) Supplements Market

34. Recent Developments In The Docosahexaenoic Acid (DHA) Supplements Market

35. Docosahexaenoic Acid (DHA) Supplements Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기